Injectable Drug Delivery Market To Be Driven By Rising Number Of Chronic Diseases Like Diabetes And Cancer Till 2024
Aug 31, 2016
According to the report published by Grand View research, global injectable drug delivery market will reach $931.1 Billion By 2024, With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.
San Francisco, California, United States - August 31, 2016 /MarketersMedia/ —
The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.
With the advent of self-injection devices, injectable drugs can be self administered without the need of medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.
The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.
The injectable drug delivery industry by end-user application is categorized into hospitals, homecare settings, and others including research establishments, diagnostics, and clinical laboratories.
Access full research report: http://www.grandviewresearch.com/industry-analysis/injectable-drug-delivery-devices-industry
Key finding:
• North America is expected to lead the market for injectable drug delivery devices with the largest number of patients suffering from chronic diseases like diabetes and cancer along with autoimmune disorders. The reason why countries in North America are leading is due to the technological innovations and advanced research in the area that enable them to excel at designing new and improved drug delivery products.
• The Asia Pacific market is set to lead exceptionally well owing to the partnerships with other well established global players. This region has also witnessed enormous investments in research and development; thus, accelerating the growth of the injectables market in this region.
• The homecare settings has been the most profit garnering segment with a large cohort of patients suffering from chronic diseases and hence the resultant high utility of these devices at a primary level for better control and management of the disease.
• Some key market players include Pfizer, Inc., Schott AG, Becton, Dickinson and Company, Baxter International, Inc., and ELI Lilly & Co.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Market Segment:
Injectable Drug Delivery by Type Outlook (Revenue, USD Million, 2013 - 2024)
• Devices
• Self- injection devices
• Conventional injection devices
• Formulation
• Conventional Drug Delivery
• Novel Drug Delivery
• Others
Injectable Drug Delivery Therapeutic Use Outlook (Revenue, USD Million, 2013 - 2024)
• Autoimmune disorders
• Hormonal disorders
• Oncology
• Others
Injectable Drug Delivery Devices End-User Application Outlook (Revenue, USD Million, 2013 - 2024)
• Hospitals
• Homecare Settings
• Others
Injectable Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• Europe
• Asia Pacific
• Latin America
• MEA
Access press release of this research report: http://www.grandviewresearch.com/press-release/global-injectable-drug-delivery-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.
For more information, please visit http://www.grandviewresearch.com/industry-analysis/injectable-drug-delivery-devices-industry
Contact Info:
Name: Sherry James
Email: [email protected]
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058
Release ID: 130466
More News
Fed Holds Rates Steady Despite Lack of Progress on Inflation
Kevin M. Warsh, the chairman of the Federal Reserve, said an “information-rich” period before the central bank’s gathering in December will help officials determine next steps for policy.
CNN, MS Now and Politico Update Lawsuit Against Trump Over White House Access
The news outlets argued in an updated lawsuit that they should be granted access to the White House reporting pools.
Restaurants sceptical over 'garlic and gherkins' plan
Import tariffs on more than 100 items - including garlic, gherkins and plant-based milk - are being removed.
From Senate Candidates, Surprising Stances on Fixing Social Security
Congress needs a plan to prevent the program’s funds from running short by 2032. Many Senate candidates have shared their positions — some of them unexpected.
What we now know about the UK economy in four charts
The Office for Budget Responsibility says higher energy prices will impact everything from prices and living standards to economic growth.
Fed Will Hold Fewer Rate-Setting Meetings Starting Next Year
Kevin M. Warsh, the Federal Reserve’s chairman, said the central bank would vote on interest rates seven times in 2027 and six in 2028. It has traditionally voted eight times per year.
What the Budget offers for under 25s - and what it leaves out
The chancellor announced a series of measures which will impact under-25 year-olds from housing to minimum wage.
Gina Hinojosa’s Texas Governor Campaign Tests Limits of New Rules for Digital Political Ads
Some of the social media posts paid for by Gina Hinojosa’s campaign for Texas governor don’t include a disclosure, despite a state regulation that likely requires it.
Dharshini David: Healey buys himself some time, but big questions still unanswered
The chancellor talked of charting a new course for Britain, but the impact of Iran war has limited his options.
An ‘Endless’ Cruise Around the World Is Suspended, Leaving Passengers Stranded
The cruise promised a lifetime of sailing, for less than what it cost to live on land. But it was underfunded and couldn’t absorb the rising cost of fuel.
Elon Musk is a 'real genius', Putin says after satellite talks with SpaceX boss
The Russian President praised Musk and said they are in "close" contact.
AI Is Finding a Flood of Bugs, and Silicon Valley Is Rushing to Fix Them
A.I. has uncovered a horde of software flaws, which engineers are racing to fix before they can be exploited and abused by hackers.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.